Retatrutide 10mg (10 Vials / Kit)

What is Retatrutide?

Retatrutide (LY3437943) is a single synthetic peptide engineered to activate three receptors: GLP-1, GIP and glucagon. It carries a fatty-acid modification that supports once-weekly pharmacokinetics in research settings.

Mechanism of Action

GLP-1 and GIP agonism support glucose-dependent insulin secretion, delayed gastric emptying and reduced appetite signalling. Added glucagon-receptor activity increases hepatic fat oxidation and energy expenditure—a distinguishing feature compared with dual incretin agonists.

Research Applications

Retatrutide is studied in obesity, type 2 diabetes and hepatic steatosis research, where the tri-agonist approach is compared against single and dual incretin agonists for effects on body composition and liver fat.

Storage & Handling

Supplied as a lyophilized (freeze-dried) powder for maximum stability. Store unopened vials at -20°C, protected from light. Once reconstituted with bacteriostatic water, keep refrigerated at 2–8°C and use within the timeframe appropriate to your study protocol.

Research Use Only

This product is intended as a research chemical only. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.